durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['nsclc', 'aegean', 'sclc']
during the clinical trials plenary session on today at 3pm, will discuss results of the phase iii #aegean trial. #aacr23 #clinicaltrials #nsclc 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.